GQG Partners’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,625,795
| Closed | -$776M | – | 105 |
|
|
2026
Q1 | $776M | Sell |
2,625,795
-1,582,664
| -38% | -$470M | 1.23% | 32 |
|
|
2025
Q4 | $1.15B | Sell |
4,208,459
-315,193
| -7% | -$85.6M | 1.89% | 17 |
|
|
2025
Q3 | $1.22B | Buy |
4,523,652
+949,964
| +27% | +$258M | 1.88% | 19 |
|
|
2025
Q2 | $985M | Buy |
3,573,688
+1,368,647
| +62% | +$372M | 1.4% | 27 |
|
|
2025
Q1 | $585M | Buy |
2,205,041
+2,176,685
| +7,676% | +$537M | 0.93% | 32 |
|
|
2024
Q4 | $6.59M | Sell |
28,356
-2,044,609
| -99% | -$470M | 0.01% | 66 |
|
|
2024
Q3 | $457M | Buy |
2,072,965
+2,045,464
| +7,438% | +$423M | 0.72% | 37 |
|
|
2024
Q2 | $5.41M | Buy |
27,501
+1,253
| +5% | +$259K | 0.01% | 57 |
|
|
2024
Q1 | $5.65M | Sell |
26,248
-641
| -2% | -$135K | 0.01% | 60 |
|
|
2023
Q4 | $5.66M | Buy |
+26,889
| New | +$5.74M | 0.01% | 57 |
|
|
2023
Q2 | – | Sell |
-11,362
| Closed | -$2.18M | – | 75 |
|
|
2023
Q1 | $2.18M | Buy |
11,362
+1,212
| +12% | +$219K | 0.01% | 71 |
|
|
2022
Q4 | $1.71M | Hold |
10,150
| – | – | ﹤0.01% | 74 |
|
|
2022
Q3 | $1.8M | Buy |
10,150
+1,125
| +12% | +$222K | 0.01% | 74 |
|
|
2022
Q2 | $1.85M | Buy |
9,025
+2,468
| +38% | +$523K | ﹤0.01% | 64 |
|
|
2022
Q1 | $1.56M | Buy |
6,557
+368
| +6% | +$86.4K | ﹤0.01% | 62 |
|
|
2021
Q4 | $1.41M | Buy |
6,189
+4,292
| +226% | +$944K | ﹤0.01% | 67 |
|
|
2021
Q3 | $367K | Buy |
1,897
+471
| +33% | +$95.4K | ﹤0.01% | 80 |
|
|
2021
Q2 | $303K | Buy |
+1,426
| New | +$301K | ﹤0.01% | 73 |
|
|
2020
Q4 | – | Sell |
-29,447
| Closed | -$4.92M | – | 66 |
|
|
2020
Q3 | $4.92M | Buy |
29,447
+176
| +0.6% | +$29.6K | 0.02% | 56 |
|
|
2020
Q2 | $4.76M | Buy |
29,271
+725
| +3% | +$130K | 0.02% | 52 |
|
|
2020
Q1 | $4.95M | Buy |
+28,546
| New | +$5.68M | 0.03% | 48 |
|
|
2019
Q2 | – | Sell |
-725,003
| Closed | -$119M | – | 47 |
|
|
2019
Q1 | $119M | Sell |
725,003
-135,582
| -16% | -$24M | 1.48% | 22 |
|
|
2018
Q4 | $162M | Buy |
860,585
+86,843
| +11% | +$16M | 2.5% | 16 |
|
|
2018
Q3 | $131M | Buy |
773,742
+320,549
| +71% | +$54M | 2.14% | 17 |
|
|
2018
Q2 | $63.8M | Buy |
453,193
+55,879
| +14% | +$9.13M | 1.52% | 25 |
|
|
2018
Q1 | $64.3M | Buy |
397,314
+255,936
| +181% | +$40.7M | 1.66% | 21 |
|
|
2017
Q4 | $20.6M | Buy |
+141,378
| New | +$20.1M | 0.65% | 36 |
|
|
2017
Q2 | – | Sell |
-2,027
| Closed | -$241K | – | 56 |
|
|
2017
Q1 | $241K | Sell |
2,027
-3,800
| -65% | -$457K | 0.05% | 45 |
|
|
2016
Q4 | $672K | Buy |
+5,827
| New | +$648K | 0.47% | 30 |
|
Other funds holding CME
GQG Partners's CME Position: Q2 2026 in Review
GQG Partners sold out of CME Group (CME) in Q2 2026, closing a stake of 2,625,795 shares — an estimated $776M sold.
GQG Partners first reported a position in CME in Q4 2016 and held it in 29 quarters. The position peaked at $1.22B in Q3 2025. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- GQG Partners reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
- GQG Partners sold 2,625,795 CME Group shares in Q2 2026, an estimated $776M.
- GQG Partners first reported a position in CME Group in Q4 2016 and held it in 29 quarters.
- GQG Partners's CME Group position peaked at $1.22B in Q3 2025.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on GQG Partners's 13F filing for Q2 2026, filed 12 Aug 2026.